Actively Recruiting

Phase Not Applicable
Age: 50Years - 85Years
All Genders
Healthy Volunteers
NCT04983823

Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

Led by Baker Heart and Diabetes Institute · Updated on 2025-10-03

820

Participants Needed

1

Research Sites

214 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective study in which a process of identifying and improving a reduction of functional capacity in COVID-19 survivors \>50 years old. The overall goal of this study to identify the feasibility and value of risk-guided medical therapy and exercise intervention in COVID-19 survivors.

CONDITIONS

Official Title

Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

Who Can Participate

Age: 50Years - 85Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • History of COVID-19 infection
  • Live within a geographically accessible area for follow-up
  • Age between 50 and 85 years
Not Eligible

You will not qualify if you...

  • Valvular stenosis or regurgitation of more than moderate severity
  • History of previous heart failure with baseline NYHA classification greater than 2
  • Inability to acquire interpretable images from baseline echocardiogram
  • Contraindications to beta blockers or angiotensin-converting enzyme inhibitors
  • Life expectancy less than 12 months due to cancer or other medical conditions including pregnancy
  • Already taking both angiotensin converting enzyme inhibitors/angiotensin receptor blockers and beta blockers, or intolerance/allergy to both
  • Mobility impairment affecting ability to perform exercise
  • Unable to provide written informed consent to participate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Baker Heart and Diabetes Institute

Melbourne, Victoria, Australia, 3004

Actively Recruiting

Loading map...

Research Team

J

Joel Smith, MSc

CONTACT

T

Thomas H Marwick, MD,PhD,MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SCREENING

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here